Optimization of a new MR protocol measuring iron content in gastrointestinal cancer

Optimization of a new MR protocol measuring iron content in gastrointestinal cancer - Gastrointestinal tumor iron measurement (GIRON)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48263

Enrollment

100

Registered

2019-05-28

Start date

2019-07-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer with liver metastasis pancreatic cancer) and with a clinical indication for MR examination Patients with gastrointestinal cancer (including rectum cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients with gastrointestinal cancer (including rectum cancer, colon cancer with liver metastasis, pancreatic cancer) and with a clinical indication for MR examination

Exclusion criteria

Exclusion criteria: All contra-indications for MR examinations (claustrophobia, cardiac pacemaker, implants not approved for MR at the employed field-strength, metal objects, etc) Incapable to undergo prolonged MR examinatio n additonal to clinical MR examination (due to frailty of old age, general condition, etc). No informed consent for notification of study participation to the medical specialist. No informed consent for the work-up of incidental findings.

Design outcomes

Primary

Measure	Time frame
The results of the additional MR technique are compared with those of conventional MR techniques. The additional MR protocol is evaluated for their added value, points for optimization are identified and these are included in the continuous process of development. Scientifically relevant results from this clinical pilot study will be published. Endpoints: quantity of iron on T2 * MRI, LIF score, fat fraction	—

Measure

Time frame

The results of the additional MR technique are compared with those of conventional MR techniques. The additional MR protocol is evaluated for their added value, points for optimization are identified and these are included in the continuous process of development. Scientifically relevant results from this clinical pilot study will be published. Endpoints: quantity of iron on T2 * MRI, LIF score, fat fraction

—

Countries

Netherlands

Outcome results